Previous use of quinolones: A surrogate marker for first line anti-tuberculosis drugs resistance in HIV-infected patients?

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 2, 2012, Pages 142-145

  Deutschendorf, Caroline ^a   Goldani, Luciano Z ^a   Pires dos Santos, Rodrigo ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Drug resistance; HIV; Mycobacterium tuberculosis; Quinolones

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; TUBERCULOSIS;

EID: 85027925840     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(12)70295-7     Document Type: Article

References (14)

1. Reid A., Scano F., Getahun H., et al. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006, 6:483-495.
2. Donald P.R., van Helden P.D. The global burden of tuberculosis - combating drug resistance in difficult times. N Engl J Med 2009, 23:2393-2395.
3. Wells C.D., Cegielski J.P., Nelson L.J., et al. HIV infection and multidrug-resistant tuberculosis - the perfect storm. JID 2007, 196(Suppl 1).
4. Lew W., Pai M., Oxlade O., et al. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008, 149:123-134.
5. Faustini A., Hall A.J., Perucci C.A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006, 61:158-163.
6. Global tuberculosis control: a short update to the 2009 report 2009, World Health Organization, World Health Organization.
7. Wolfart M., Barth A.L., Willers D., et al. Mycobacterium tuberculosis resistance in HIV-infected patients from a tertiary careteaching hospital in Porto Alegre, southern Brazil. Trans R Soc Trop Med Hyg 2008, 102:421-425.
8. Fandinho F., Kritski A., Hofer C., et al. Drug resistance patterns among hospitalized tuberculous patients in Rio de Janeiro, Brazil, 1993-1994. Mem Inst Oswaldo Cruz 1999, 94:543-547.
9. Pinto W.P., Hadad D.J., Silva Telles M.A., et al. Tuberculosis and drug resistance among patients seen at an AIDS reference center in Sao Paulo, Brazil. Int J Infect Dis 2001, 5:93-100.
10. Kliiman K., Altraja A. Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med 2009, 150:766-775.
11. Vashakidze L., Salakaia A., Shubladze N., et al. Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia. Int J Tuberc Lung Dis 2009, 13:1148-1153.
12. Park I.N., Hong S.B., Oh Y.M., et al. Impact of short-term exposure to quinolones on ofloxacin resistance in HIV-negative patients with tuberculosis. Int J Tuberc Lung Dis 2007, 11:319-324.
13. Wang J.Y., Lee L.N., Lai H.C., et al. Quinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. JAC 2007, 59:860-865.
14. Long R., Chong H., Hoeppner V., et al. Empirical treatment of community-acquired pneumonia and the development of quinolone-resistant tuberculosis. Clin Infect Dis 2009, 48:1354-1360.